Medytox Solutions (MMMS) 3.0000 $MMMS
Medytox Solutions, Inc. Stockholders Approve Merger With CollabRx, Inc.
Marketwired - Wed Oct 28, 4:38PM CDT
Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox"
announced today it held its Special Meeting of Stockholders to approve the following proposals: (i) to approve and adopt the Agreement and Plan of Merger, dated as of April 15, 2015, by and among CollabRx, Inc., CollabRx Merger Sub, Inc., a direct wholly owned subsidiary of CollabRx formed for the purpose of the merger, and Medytox (the "Merger Agreement", pursuant to which Medytox will become a wholly owned subsidiary of CollabRx (the "Merger", and the transactions contemplated by such agreement (the "Merger Proposal" and (ii) to approve any motion to adjourn the Special Meeting, or any adjournment thereof, to another time or place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve and adopt the Merger Agreement and the transactions contemplated thereby (the "Adjournment Proposal".
CLRX: 0.48 (+0.05)
CollabRx Adjourns Stockholder Special Meeting to October 30, 2015
GlobeNewswire - Wed Oct 28, 4:06PM CDT
CollabRx, Inc. ("CollabRx" (NASDAQ:CLRX) announced today that the special meeting of its stockholders scheduled for Wednesday, October 28, 2015 to consider and act on several proposals recommended by CollabRx's board and management regarding its proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS) has been adjourned to Friday, October 30, 2015 at 10:30 am Pacific Time, and will take place at CollabRx's offices located at 44 Montgomery Street, Suite 800, San Francisco, CA 94104-4811.
CLRX: 0.48 (+0.05)
CollabRx Stockholder Special Meeting to be Held October 28, 2015
GlobeNewswire - Thu Oct 22, 6:09AM CDT
As previously announced, CollabRx, Inc. ("CollabRx" (NASDAQ:CLRX) will hold a special meeting of its stockholders on Wednesday, October 28, 2015, to consider and act on several proposals recommended by CollabRx's board and management regarding its proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS).
CLRX: 0.48 (+0.05)
CollabRx Announces Special Meeting of Its Stockholders to Be Held October 28, 2015
GlobeNewswire - Thu Sep 24, 5:00PM CDT
CollabRx, Inc. ("CollabRx" (NASDAQ:CLRX) today announced that the registration statement on Form S-4 and the definitive joint proxy statement/prospectus contained therein, regarding CollabRx's proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS), has been declared effective by the Securities and Exchange Commission (the "SEC".
CLRX: 0.48 (+0.05)
Medytox Solutions, Inc. Announces New Board Members
Marketwired - Thu Aug 13, 10:00AM CDT
Medytox Solutions, Inc. announces the election of two new board members who boast years of professional leadership in corporate governance, financial services, company restructuring, and healthcare. Michael L. Goldberg, managing director of Monarch Capital, LLC, and Robert Lee, managing partner of Sheffield Investment Partners, joined returning board members Christopher E. Diamantis, chairman and CEO of Integrated Financial Settlements, Inc.; Benjamin Frank, a retired lawyer and businessman with experience in healthcare, foreign trade, retail, business development, and government; and Seamus Lagan, CEO of Medytox Solutions, Inc. The election took place at the annual stockholders' meeting of Medytox Solutions, Inc. on August 6, 2015.
July Brings Winning Streak Of Massive Cash Jackpots To Table Mountain Casino Players Club Members
PR Newswire - Mon Jul 20, 7:13PM CDT
Reel luck and huge winnings have Table Mountain Casino Club Members getting their win on as yet another random Massive Cash Jackpot paid out again--the third one in a string of BIG jackpots to hit.
CollabRx Announces Receipt of NASDAQ Notice of Noncompliance for Bid Price
GlobeNewswire - Fri Jun 05, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company", announced today that it received a letter from The NASDAQ Stock Market LLC ("Nasdaq" stating that the bid price of the Company's common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2).
CLRX: 0.48 (+0.05)
Table Mountain Casino's Massive Cash Jackpot Pays Yet Another Lucky Winner
PR Newswire - Mon Jun 01, 6:32PM CDT
Table Mountain Casino's Lucky Club member, Gurdial of Fresno, visited his favorite casino, Table Mountain, and left with a mountain of money! The popular Massive Cash jackpot randomly paid out on the machine he was playing, showering him with $100,604.82 in cold hard cash!
CollabRx Receives Notice From Nasdaq on Change of Control
GlobeNewswire - Wed Apr 29, 6:01AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" or "the Company", today announced that it had received notice from The NASDAQ Stock Market LLC ("Nasdaq" that the Company's proposed transaction with Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox" when completed would constitute a business combination that results in a "change of control" as that term is defined in Nasdaq Listing Rule 5110(a). Accordingly, the post-transaction entity would be required to successfully complete the Nasdaq listing application process and satisfy all criteria for initial listing on Nasdaq.
CLRX: 0.48 (+0.05)
CollabRx and Medytox Solutions Sign Definitive Merger Agreement
GlobeNewswire - Thu Apr 16, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox" today announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions.
CLRX: 0.48 (+0.05)
Medytox Solutions Signs Definitive Merger Agreement With CollabRx
GlobeNewswire - Thu Apr 16, 6:00AM CDT
Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox" and CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" today announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions.
CLRX: 0.48 (+0.05)
Integrated Healthcare Company, Medytox Solutions, Inc., Names New COO
Marketwired - Wed Feb 18, 10:00AM CST
Medytox Solutions, Inc. (OTCBB: MMMS), which owns and operates clinical laboratories and healthcare technology companies, announced today that it named Samuel R. Mitchell, Jr., chief operating officer. As COO, Mr. Mitchell will work to streamline performance throughout the Medytox family of companies headquartered in West Palm Beach. He will also oversee quarterly and annual financial goal management.
CollabRx announces non-binding letter of intent for proposed business combination with Medytox Solutions
M2 - Fri Jan 23, 8:03PM CST
Medical information company CollabRx (NasdaqCM:CLRX) reported on Thursday the execution of a non-binding letter of intent to negotiate a potential business combination with Medytox Solutions (OTCBB:MMMS).
CLRX: 0.48 (+0.05)
CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination
Marketwired - Thu Jan 22, 5:30AM CST
CollabRx, Inc. (NASDAQ: CLRX) and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox" have entered into a non-binding letter of intent to negotiate a potential business combination. Also, CollabRx and Medytox announced that they have entered into agreements that would secure funding needed by CollabRx to continue to operate while the parties negotiate a potential business combination. The potential business combination is subject to, among other things, due diligence, the execution of a definitive agreement, necessary Board of Directors and stockholder approvals and other customary conditions.
CLRX: 0.48 (+0.05)
Medytox Diagnostics' International Technologies awarded the New York State Department's Health Clinical Laboratory permit
M2 - Thu Jan 08, 4:53AM CST
Medytox Diagnostics stated on Wednesday that its New Jersey-based laboratory, International Technologies, has been certified with a Clinical Laboratory Permit by the New York State Department of Health.
Medytox Diagnostics Awarded License to Begin Lab Testing in New York State
Marketwired - Wed Jan 07, 10:06AM CST
The New York State Department of Health awarded Medytox Diagnostics, Inc.'s New Jersey-based laboratory, International Technologies, LLC, with a Clinical Laboratory Permit that allows the lab to begin servicing clients throughout New York State with a full continuum of laboratory services, including sophisticated drug screening. Medytox Diagnostics, a subsidiary of Medytox Solutions, Inc. (OTCBB: MMMS), has carved a niche serving the drug testing needs of substance abuse facilities and pain management practices at its New Jersey lab and its network of laboratories nationwide.
CORRECTION - Medytox Billing Subsidiary Expands Patient Relations Department
Marketwired - Tue Dec 30, 9:00AM CST
In the news release, "Medytox Billing Subsidiary Expands Patient Relations Department," issued Wednesday, December 24, 2014 by Medytox Solutions, Inc. (OTCBB: MMMS), we are advised by the company that the fourth paragraph should read "William DePond, M.D., COO of Medytox Diagnostics, Inc., and CEO of Medytox-owned laboratories" rather than "William DePond, M.D., COO of Medytox Solutions, Inc., and CEO of Medytox laboratories" as originally issued. Complete corrected text follows.
Medytox Solutions, Inc. Stockholders Approve Merger With CollabRx, Inc.
Marketwired - Wed Oct 28, 4:38PM CDT
Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox"
announced today it held its Special Meeting of Stockholders to approve the following proposals: (i) to approve and adopt the Agreement and Plan of Merger, dated as of April 15, 2015, by and among CollabRx, Inc., CollabRx Merger Sub, Inc., a direct wholly owned subsidiary of CollabRx formed for the purpose of the merger, and Medytox (the "Merger Agreement", pursuant to which Medytox will become a wholly owned subsidiary of CollabRx (the "Merger", and the transactions contemplated by such agreement (the "Merger Proposal" and (ii) to approve any motion to adjourn the Special Meeting, or any adjournment thereof, to another time or place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve and adopt the Merger Agreement and the transactions contemplated thereby (the "Adjournment Proposal". CLRX: 0.48 (+0.05)
CollabRx Adjourns Stockholder Special Meeting to October 30, 2015
GlobeNewswire - Wed Oct 28, 4:06PM CDT
CollabRx, Inc. ("CollabRx"
(NASDAQ:CLRX) announced today that the special meeting of its stockholders scheduled for Wednesday, October 28, 2015 to consider and act on several proposals recommended by CollabRx's board and management regarding its proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS) has been adjourned to Friday, October 30, 2015 at 10:30 am Pacific Time, and will take place at CollabRx's offices located at 44 Montgomery Street, Suite 800, San Francisco, CA 94104-4811. CLRX: 0.48 (+0.05)
CollabRx Stockholder Special Meeting to be Held October 28, 2015
GlobeNewswire - Thu Oct 22, 6:09AM CDT
As previously announced, CollabRx, Inc. ("CollabRx"
(NASDAQ:CLRX) will hold a special meeting of its stockholders on Wednesday, October 28, 2015, to consider and act on several proposals recommended by CollabRx's board and management regarding its proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS). CLRX: 0.48 (+0.05)
CollabRx Announces Special Meeting of Its Stockholders to Be Held October 28, 2015
GlobeNewswire - Thu Sep 24, 5:00PM CDT
CollabRx, Inc. ("CollabRx"
(NASDAQ:CLRX) today announced that the registration statement on Form S-4 and the definitive joint proxy statement/prospectus contained therein, regarding CollabRx's proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS), has been declared effective by the Securities and Exchange Commission (the "SEC". CLRX: 0.48 (+0.05)
Medytox Solutions, Inc. Announces New Board Members
Marketwired - Thu Aug 13, 10:00AM CDT
Medytox Solutions, Inc. announces the election of two new board members who boast years of professional leadership in corporate governance, financial services, company restructuring, and healthcare. Michael L. Goldberg, managing director of Monarch Capital, LLC, and Robert Lee, managing partner of Sheffield Investment Partners, joined returning board members Christopher E. Diamantis, chairman and CEO of Integrated Financial Settlements, Inc.; Benjamin Frank, a retired lawyer and businessman with experience in healthcare, foreign trade, retail, business development, and government; and Seamus Lagan, CEO of Medytox Solutions, Inc. The election took place at the annual stockholders' meeting of Medytox Solutions, Inc. on August 6, 2015.
July Brings Winning Streak Of Massive Cash Jackpots To Table Mountain Casino Players Club Members
PR Newswire - Mon Jul 20, 7:13PM CDT
Reel luck and huge winnings have Table Mountain Casino Club Members getting their win on as yet another random Massive Cash Jackpot paid out again--the third one in a string of BIG jackpots to hit.
CollabRx Announces Receipt of NASDAQ Notice of Noncompliance for Bid Price
GlobeNewswire - Fri Jun 05, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company"
, announced today that it received a letter from The NASDAQ Stock Market LLC ("Nasdaq" stating that the bid price of the Company's common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2). CLRX: 0.48 (+0.05)
Table Mountain Casino's Massive Cash Jackpot Pays Yet Another Lucky Winner
PR Newswire - Mon Jun 01, 6:32PM CDT
Table Mountain Casino's Lucky Club member, Gurdial of Fresno, visited his favorite casino, Table Mountain, and left with a mountain of money! The popular Massive Cash jackpot randomly paid out on the machine he was playing, showering him with $100,604.82 in cold hard cash!
CollabRx Receives Notice From Nasdaq on Change of Control
GlobeNewswire - Wed Apr 29, 6:01AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" or "the Company"
, today announced that it had received notice from The NASDAQ Stock Market LLC ("Nasdaq" that the Company's proposed transaction with Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox" when completed would constitute a business combination that results in a "change of control" as that term is defined in Nasdaq Listing Rule 5110(a). Accordingly, the post-transaction entity would be required to successfully complete the Nasdaq listing application process and satisfy all criteria for initial listing on Nasdaq. CLRX: 0.48 (+0.05)
CollabRx and Medytox Solutions Sign Definitive Merger Agreement
GlobeNewswire - Thu Apr 16, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx"
and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox" today announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions. CLRX: 0.48 (+0.05)
Medytox Solutions Signs Definitive Merger Agreement With CollabRx
GlobeNewswire - Thu Apr 16, 6:00AM CDT
Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox"
and CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" today announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions. CLRX: 0.48 (+0.05)
Integrated Healthcare Company, Medytox Solutions, Inc., Names New COO
Marketwired - Wed Feb 18, 10:00AM CST
Medytox Solutions, Inc. (OTCBB: MMMS), which owns and operates clinical laboratories and healthcare technology companies, announced today that it named Samuel R. Mitchell, Jr., chief operating officer. As COO, Mr. Mitchell will work to streamline performance throughout the Medytox family of companies headquartered in West Palm Beach. He will also oversee quarterly and annual financial goal management.
CollabRx announces non-binding letter of intent for proposed business combination with Medytox Solutions
M2 - Fri Jan 23, 8:03PM CST
Medical information company CollabRx (NasdaqCM:CLRX) reported on Thursday the execution of a non-binding letter of intent to negotiate a potential business combination with Medytox Solutions (OTCBB:MMMS).
CLRX: 0.48 (+0.05)
CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination
Marketwired - Thu Jan 22, 5:30AM CST
CollabRx, Inc. (NASDAQ: CLRX) and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox"
have entered into a non-binding letter of intent to negotiate a potential business combination. Also, CollabRx and Medytox announced that they have entered into agreements that would secure funding needed by CollabRx to continue to operate while the parties negotiate a potential business combination. The potential business combination is subject to, among other things, due diligence, the execution of a definitive agreement, necessary Board of Directors and stockholder approvals and other customary conditions. CLRX: 0.48 (+0.05)
Medytox Diagnostics' International Technologies awarded the New York State Department's Health Clinical Laboratory permit
M2 - Thu Jan 08, 4:53AM CST
Medytox Diagnostics stated on Wednesday that its New Jersey-based laboratory, International Technologies, has been certified with a Clinical Laboratory Permit by the New York State Department of Health.
Medytox Diagnostics Awarded License to Begin Lab Testing in New York State
Marketwired - Wed Jan 07, 10:06AM CST
The New York State Department of Health awarded Medytox Diagnostics, Inc.'s New Jersey-based laboratory, International Technologies, LLC, with a Clinical Laboratory Permit that allows the lab to begin servicing clients throughout New York State with a full continuum of laboratory services, including sophisticated drug screening. Medytox Diagnostics, a subsidiary of Medytox Solutions, Inc. (OTCBB: MMMS), has carved a niche serving the drug testing needs of substance abuse facilities and pain management practices at its New Jersey lab and its network of laboratories nationwide.
CORRECTION - Medytox Billing Subsidiary Expands Patient Relations Department
Marketwired - Tue Dec 30, 9:00AM CST
In the news release, "Medytox Billing Subsidiary Expands Patient Relations Department," issued Wednesday, December 24, 2014 by Medytox Solutions, Inc. (OTCBB: MMMS), we are advised by the company that the fourth paragraph should read "William DePond, M.D., COO of Medytox Diagnostics, Inc., and CEO of Medytox-owned laboratories" rather than "William DePond, M.D., COO of Medytox Solutions, Inc., and CEO of Medytox laboratories" as originally issued. Complete corrected text follows.
